These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 9825825)

  • 1. Acute intestinal graft-versus-host disease in a syngeneic bone marrow transplant recipient.
    Spaner D; Lowsky R; Fyles G; Lipton JH; Banerjee D; Ng CM; Wade JA; Messner HA
    Transplantation; 1998 Nov; 66(9):1251-3. PubMed ID: 9825825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progressive autologous graft-versus-host disease induced by cyclosporin A.
    Barredo JC; Yusuf U; Hahn A; Abboud MR; Laver J
    Bone Marrow Transplant; 1996 Sep; 18(3):659-62. PubMed ID: 8879637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of cyclosporine-induced syngeneic graft-versus-host disease in bone marrow transplantation by UV-B irradiated bone marrow cells.
    Ohajekwe OA; James T; Hardy MA; Oluwole SF
    Bone Marrow Transplant; 1995 Apr; 15(4):627-32. PubMed ID: 7655391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase I trial of interferon gamma to potentiate cyclosporine-induced graft-versus-host disease in women undergoing autologous bone marrow transplantation for breast cancer.
    Kennedy MJ; Vogelsang GB; Jones RJ; Farmer ER; Hess AD; Altomonte V; Huelskamp AM; Davidson NE
    J Clin Oncol; 1994 Feb; 12(2):249-57. PubMed ID: 8113833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclosporine-induced graft-versus-host disease after autologous bone marrow transplantation for acute myeloid leukemia.
    Yeager AM; Vogelsang GB; Jones RJ; Farmer ER; Hess AD; Santos GW
    Leuk Lymphoma; 1993 Oct; 11(3-4):215-20. PubMed ID: 8260896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute skin GVHD following syngeneic BMT for CLL.
    Deane M; Singer C; Lawler M; McElwaine S; Gomez K; Prentice HG
    Bone Marrow Transplant; 1998 Dec; 22(12):1207-9. PubMed ID: 9894725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Close simulation of acute graft-versus-host disease by interleukin-2 administered after autologous bone marrow transplantation for hematologic malignancy.
    Massumoto C; Benyunes MC; Sale G; Beauchamp M; York A; Thompson JA; Buckner CD; Fefer A
    Bone Marrow Transplant; 1996 Mar; 17(3):351-6. PubMed ID: 8704686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase I study of alpha-interferon augmentation of cyclosporine-induced graft versus host disease in recipients of autologous bone marrow transplantation.
    Ratanatharathorn V; Uberti J; Karanes C; Lum LG; Abella E; Dan ME; Hussein M; Sensenbrenner LL
    Bone Marrow Transplant; 1994 May; 13(5):625-30. PubMed ID: 8054915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic aspergillosis in a patient with non-Hodgkin's lymphoma developing acute graft-versus-host disease after autologous peripheral blood stem cell transplantation.
    Messina G; Quartarone E; Console G; Cuzzola M; Iacopino O; Martino M; Irrera G; Morabito F; Iacopino P
    Haematologica; 2002 Jul; 87(7):ECR22. PubMed ID: 12091138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of graft-versus-host disease after autologous bone marrow transplantation.
    Jones RJ; Vogelsang GB; Hess AD; Farmer ER; Mann RB; Geller RB; Piantadosi S; Santos GW
    Lancet; 1989 Apr; 1(8641):754-7. PubMed ID: 2564566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune modulation in autologous bone marrow transplantation: cyclosporine and gamma-interferon trial.
    Vogelsang G; Bitton R; Piantadosi S; Altomonte V; Horn T; Jones R; Miller C; Marcellus D; Abrams R; Hess A
    Bone Marrow Transplant; 1999 Sep; 24(6):637-40. PubMed ID: 10490729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Marrow transplant experience for children with severe aplastic anemia.
    Sanders JE; Storb R; Anasetti C; Deeg HJ; Doney K; Sullivan KM; Witherspoon RP; Hansen J
    Am J Pediatr Hematol Oncol; 1994 Feb; 16(1):43-9. PubMed ID: 8311172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 15-Deoxyspergualin controls cyclosporin- and steroid-resistant intestinal acute graft-versus-host disease after allogeneic bone marrow transplantation.
    Kasai M; Higa T; Naohara T; Masauzi N; Watanabe M; Matsuura A; Ohizumi H; Tanaka J; Morii K; Kiyama Y
    Bone Marrow Transplant; 1994 Aug; 14(2):315-7. PubMed ID: 7994248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Syngeneic graft-versus-host disease: a report of two cases and literature review.
    Latif T; Pohlman B; Kalaycio M; Sobecks R; Hsi ED; Andresen S; Bolwell BJ
    Bone Marrow Transplant; 2003 Sep; 32(5):535-9. PubMed ID: 12942102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Graft-versus-leukaemia activity associated with CMV-seropositive donor, post-transplant CMV infection, young donor age and chronic graft-versus-host disease in bone marrow allograft recipients. The Nordic Bone Marrow Transplantation Group.
    Jacobsen N; Badsberg JH; Lönnqvist B; Ringdén O; Volin L; Rajantie J; Nikoskelainen J; Keiding N
    Bone Marrow Transplant; 1990 Jun; 5(6):413-8. PubMed ID: 2164434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Omission of day 11 methotrexate does not appear to influence the incidence of moderate to severe acute graft-versus-host disease, chronic graft-versus-host disease, relapse rate or survival after HLA-identical sibling bone marrow transplantation.
    Atkinson K; Downs K
    Bone Marrow Transplant; 1995 Dec; 16(6):755-8. PubMed ID: 8750265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement of cyclosporin A-induced autologous graft-versus-host disease after peripheral blood stem cell transplantation by utilizing selected CD34(+) cells.
    Miura Y; Ueda M; Takami A; Shiobara S; Nakao S; Hess AD
    Bone Marrow Transplant; 2003 Oct; 32(8):785-90. PubMed ID: 14520422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microangiopathy following allogeneic marrow transplantation. Association with cyclosporine and methylprednisolone for graft-versus-host disease prophylaxis.
    Kalhs P; Brugger S; Schwarzinger I; Greinix HT; Keil F; Kyrle PA; Knöbl P; Schneider B; Höcker P; Linkesch W
    Transplantation; 1995 Nov; 60(9):949-57. PubMed ID: 7491699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Graft-versus-host disease after marrow transplantation.
    Storb R
    Prog Clin Biol Res; 1986; 224():139-57. PubMed ID: 3540990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allogeneic transplantation for recurrent or refractory non-Hodgkin's lymphoma with poor prognostic features after conditioning with thiotepa, busulfan, and cyclophosphamide: experience in 44 consecutive patients.
    van Besien K; Thall P; Korbling M; Pugh WC; Khouri I; Mehra R; Giralt S; Anderlini P; Amin K; Mirza N; Seong D; Gajewski J; Hester J; Andersson B; Cabanillas F; Champlin R; Przepiorka D
    Biol Blood Marrow Transplant; 1997 Aug; 3(3):150-6. PubMed ID: 9310192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.